Korro Bio, Inc.KRRONASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank75
3Y CAGR+22.4%
5Y CAGR+3.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+22.4%/yr
vs +25.8%/yr prior
5Y CAGR
+3.2%/yr
Recent acceleration
Acceleration
-3.3pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$30.83M+0.9%
2024$30.55M-16.4%
2023$36.54M+117.5%
2022$16.80M-51.9%
2021$34.93M+32.8%
2020$26.30M+81.7%
2019$14.47M+115.7%
2018$6.71M+68.2%
2017$3.99M-